Article Figures & Data
Figures
- Fig 1.
Algorithm for the assessment and treatment of an athlete with suspected airways disease. ∗FEV1>12% from baseline value in response to inhaled beta-2 agonist; †positive if FEV1 falls by >10% from baseline value (check guidelines for more detail). EIB = exercise-induced bronchoconstriction; FEV1= forced expiratory volume in 1 sec; FVC = forced vital capacity; ICS = inhaled corticosteroid; SABA = short-acting beta-2 agonist.
- Fig 2.
Approach to management of allergic rhinitis in competitive athletes.
Adapted with permission.19 AR = allergic rhinitis; EIB = exercise-induced bronchoconstriction; LTRA = leukotriene receptor antagonist.
Tables
Jump to section
- Article
- Abstract
- Introduction
- Assessing respiratory symptoms in athletes
- Respiratory conditions in athletes
- Airways disease
- Respiratory tract infection
- Pneumothorax
- Exercise-induced anaphylaxis
- Specific considerations when treating athletes
- Anti-doping and/or consideration of prohibited substances
- Conclusions
- Details of competing interests:
- Acknowledgements
- References
- Figures & Data
- Info & Metrics
Related Articles
Cited By...
- Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians
- High prevalence of exercise-induced stridor during Parkrun: a cross-sectional field-based evaluation
- Validity and reliability of grade scoring in the diagnosis of exercise-induced laryngeal obstruction
- Lesson of the month: rowing-induced laryngeal obstruction: a novel cause of exertional dyspnoea: characterised by direct laryngoscopy
- High-performance sports medicine